Overbought Stocks — Financial View · Biological Products, (No Diagnostic Substances)
8 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Financial columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–8 of 8
| TARS | Tarsus Pharmaceuticals, Inc. | $3.6B | 0.0% | -7.6% | -13.4% | -11.1% | 3.20 | 0.21 | — | -8.0% | -7.7% | 83.12 | +0.41% | 43K |
| APGE | Apogee Therapeutics, Inc. | $10.2B | — | -22.0% | — | — | 26.44 | — | — | — | — | 135.08 | +0.04% | 89K |
| ALVO | Alvotech | — | — | — | — | — | — | — | — | — | — | 5.37 | +0.56% | 74K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | — | 16.0% | — | 19.9% | 2.71 | 13.50 | 82.4% | 35.9% | 24.9% | 110.73 | +1.01% | 90K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | — | 9.39 | -0.11 | — | — | — | 25.33 | +3.56% | 23K |
| NVAX | Novavax Inc | $1.7B | — | -25.9% | — | — | 2.33 | -1.53 | 29.0% | -20.8% | -22.1% | 10.34 | +0.19% | 229K |
| CRDL | Cardiol Therapeutics Inc. | — | — | — | — | — | — | — | — | — | — | 2.15 | -0.23% | 66K |
| IOVA | Iovance Biotherapeutics, Inc. | $4.0B | — | -31.6% | -39.3% | -39.3% | 4.35 | 0.24 | 48.4% | -92.7% | -89.1% | 8.80 | +2.09% | 641K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.